Suppr超能文献

硬皮病中平滑肌、横纹肌和心肌的参与:综述。

The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.

机构信息

Department of Rheumatology and Physiotherapy, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania.

Department of Pharmacology, "Grigore T. Popa" University of Medicine and Pharmacy, 16 University Street, 700115 Iasi, Romania.

出版信息

Int J Mol Sci. 2022 Oct 9;23(19):12011. doi: 10.3390/ijms231912011.

Abstract

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by heterogeneous changes involving numerous organs and systems. The currently available data indicate that muscle injury (both smooth and striated muscles) is widespread and leads to significant morbidity, either directly or indirectly. From the consequences of smooth muscle involvement in the tunica media of blood vessels or at the level of the digestive tract, to skeletal myopathy (which may be interpreted strictly in the context of SSc, or as an overlap with idiopathic inflammatory myopathies), muscular injury in scleroderma translates to a number of notable clinical manifestations. Heart involvement in SSc is heterogenous depending on the definition used in the various studies. The majority of SSc patients experience a silent form of cardiac disease. The present review summarizes certain important features of myocardial, as well as smooth and skeletal muscle involvement in SSc. Further research is needed to fully describe and understand the pathogenic pathways and the implications of muscle involvement in scleroderma.

摘要

系统性硬化症(SSc)是一种复杂的自身免疫性疾病,其特征为涉及众多器官和系统的异质性变化。目前的数据表明,肌肉损伤(平滑肌和横纹肌)广泛存在,并直接或间接导致显著的发病率。从血管中层的平滑肌受累或消化道的平滑肌受累的后果,到骨骼肌病(可能在 SSc 背景下严格解释,或与特发性炎性肌病重叠),硬皮病中的肌肉损伤可转化为多种显著的临床表现。根据在各种研究中使用的定义,SSc 中的心脏受累具有异质性。大多数 SSc 患者经历一种无症状的心脏疾病。本综述总结了 SSc 中心肌、平滑肌和骨骼肌受累的某些重要特征。需要进一步研究来充分描述和理解肌肉受累在硬皮病中的发病机制和影响。

相似文献

1
The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review.
Int J Mol Sci. 2022 Oct 9;23(19):12011. doi: 10.3390/ijms231912011.
2
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis.
Arthritis Res Ther. 2022 Apr 11;24(1):84. doi: 10.1186/s13075-022-02768-z.
3
Clinical and laboratory features of scleroderma patients developing skeletal myopathy.
Clin Rheumatol. 2005 Apr;24(2):99-102. doi: 10.1007/s10067-004-0975-7. Epub 2004 Aug 20.
5
Systemic sclerosis-associated myopathy.
Ann N Y Acad Sci. 2007 Jun;1108:268-82. doi: 10.1196/annals.1422.029.
7
Skeletal and cardiac muscles involvement in systemic sclerosis.
Rev Bras Reumatol. 2011 Jul-Aug;51(4):309-10, 313.
9
Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases.
Autoimmun Rev. 2023 May;22(5):103311. doi: 10.1016/j.autrev.2023.103311. Epub 2023 Mar 7.

引用本文的文献

3
Skeletal Muscle Pathology in Pulmonary Arterial Hypertension and Its Contribution to Exercise Intolerance.
J Am Heart Assoc. 2025 Feb 18;14(4):e036952. doi: 10.1161/JAHA.124.036952. Epub 2025 Feb 8.
4
Musculoskeletal involvement in systemic sclerosis.
Reumatologia. 2024;62(4):274-281. doi: 10.5114/reum/190576. Epub 2024 Aug 18.
5
Heart involvement in patients with systemic sclerosis-what have we learned about it in the last 5 years.
Rheumatol Int. 2024 Oct;44(10):1823-1836. doi: 10.1007/s00296-024-05699-x. Epub 2024 Aug 27.
6
miR-27b-3p reduces muscle fibrosis during chronic skeletal muscle injury by targeting TGF-βR1/Smad pathway.
J Orthop Surg Res. 2024 Jun 2;19(1):329. doi: 10.1186/s13018-024-04733-9.
7
From Pathogenesis to Treatment-New Perspectives in Rheumatology.
Int J Mol Sci. 2023 Oct 26;24(21):15590. doi: 10.3390/ijms242115590.

本文引用的文献

1
2
Raynaud's Phenomenon with Focus on Systemic Sclerosis.
J Clin Med. 2022 Apr 28;11(9):2490. doi: 10.3390/jcm11092490.
3
Clinical, Serological, and Genetic Characteristics of a Hungarian Myositis-Scleroderma Overlap Cohort.
Biomed Res Int. 2022 May 2;2022:6251232. doi: 10.1155/2022/6251232. eCollection 2022.
4
Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis.
Arthritis Res Ther. 2022 Apr 11;24(1):84. doi: 10.1186/s13075-022-02768-z.
5
Update on assessment and management of primary cardiac involvement in systemic sclerosis.
J Scleroderma Relat Disord. 2018 Feb;3(1):53-65. doi: 10.1177/2397198317747441. Epub 2018 Apr 4.
6
Kidney involvement in systemic sclerosis: From pathogenesis to treatment.
J Scleroderma Relat Disord. 2018 Feb;3(1):43-52. doi: 10.1177/2397198318758607. Epub 2018 Apr 4.
7
Anti-nuclear autoantibodies in systemic sclerosis : News and perspectives.
J Scleroderma Relat Disord. 2018 Oct;3(3):201-213. doi: 10.1177/2397198318783930. Epub 2018 Jul 10.
8
The Prognostic Value of Right Atrial and Right Ventricular Functional Parameters in Systemic Sclerosis.
Front Cardiovasc Med. 2022 Mar 17;9:845359. doi: 10.3389/fcvm.2022.845359. eCollection 2022.
10
Sclerodermic Cardiomyopathy-A State-of-the-Art Review.
Diagnostics (Basel). 2022 Mar 9;12(3):669. doi: 10.3390/diagnostics12030669.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验